Drug Trial Radar · NCT07215468
HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies Study
Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
88
Actual
Start
Dec 16, 2025
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- TaiMed Biologics Inc.Industry
- Sponsor type
- Industry
- First posted
- Oct 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
TMB-365 is a monoclonal antibody that binds to the CD4 receptor. TMB-380, aka VRC07-523LS is a monoclonal antibody that binds to HIV. Both interfere with HIV entry. This study is designed to test the combination of the antibodies as maintenance therapy in HIV infected suppressed individuals discontinuing oral cART for 48 weeks. Researchers will compare TMB-365/TMB-380 given IV every 8 weeks to continuation of daily oral cART to see if TMB-365/TMB-380 can also maintain viral suppression. Participants will: 1. Receive TMB-365/TMB-380 infusion or take oral cART as scheduled for 48 weeks 2. Visit the clinic as schedule for checkups and tests
Conditions
- HIV -1 Infection
Interventions
TMB-365Drug
A monoclonal antibody acts as a HIV post-attachment inhibitor to be given intravenously
TMB-380Drug
A broadly neutralizing antibody (bNAb) against HIV to be given intravenously
Baseline ARTDrug
Baseline ART to be taken daily and orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Antiviral activity of TMB-365 and TMB-380 as maintenance therapy compared to daily oral cARTTime frame: Week 48
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Quest Clinical Research
San Francisco, California
CAN Community Health Fort Lauderdale
Fort Lauderdale, Florida
Midway Immunology and Research Center (MIRC)
Ft. Pierce, Florida
CAN Community Health Miami Gardens
Miami Gardens, Florida
Midland Medical
Oakland Park, Florida
Orlando Immunology Center
Orlando, Florida
CAN Community Health Sarasota
Sarasota, Florida
CAN Community Health Las Vegas
Las Vegas, Nevada
The Rockefeller University
New York, New York
The Crofoot Research Center, Inc.
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.